Efficacy and safety of tozorakimab in moderate-to-severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER-2) - Silverberg,JI; Mustapa,MN; Reid,F; Lei,A; Smith,R; Moate,R; Kelly,A; Chen,R; Gavala,M; Jimenez,E; Belvisi,MG; Sadiq,MW; et al. (JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024)